FOR IMMEDIATE RELEASEMay 12, 2020 The designation reflects AIS Healthcare’s commitment to advancing quality throughout thecare continuum. Dallas, Texas—AIS Healthcare is proud to announce that its state-of-the-art pharmacy in Ridgeland, Mississippi, which produces patient-specific prescriptions for targeted drug delivery (TDD), has received the prestigious URAC accreditation for Home Infusion Therapy Supplier (HITS). AIS Healthcare is […]
On April 28, we hosted our second webinar in response to COVID-19: Managing Pumps in the New Paradigm. This webinar offered up-to-date information on the national COVID-19 response and outlook, and included insights on the impact of COVID-19 on academic medical centers. If you have any questions, please contact us or find your rep to learn more.
FOR IMMEDIATE RELEASEApril 29, 2020 AIS Healthcare goes above and beyond to supply needed medication for COVID-19ventilator patients AIS Healthcare is leveraging its industry-leading 503A compounding facilities to help address a national medication shortage while continuing to provide existing patients with medications of the highest quality and sterility. Dallas, Texas—As part of our commitment to […]
Watch our webinar, hosted April 9th, in response to COVID-19: Managing Pumps in the New Paradigm. The webinar provides insights into the pandemic and best practices on adapting your targeted drug delivery care models from members of our medical advisory board and physician partners. If you have any questions, please contact us or find your […]
Contact:Simon Castellanos877.443.4006 FOR IMMEDIATE RELEASEMarch 16, 2020 COVID-19 response: AIS Healthcare continues to go above and beyond to protect patients and support providers In addition to our industry-leading safety and quality standards across all three of our care divisions, AIS Healthcare is implementing additional measures in response to COVID-19. Dallas, Texas—AIS Healthcare is committed to […]
The acquisition marks AIS Healthcare’s expansion into ophthalmology and a continuation of its commitment to providing patient-specific medication of the highest quality.
AIS Healthcare is proud to announce that its two state-of-the-art 503A compounding pharmacies and its four Advanced Infusion Care locations have received the prestigious URAC accreditation in Specialty Pharmacy, and its Dallas-based Care Coordination Program has been awarded URAC accreditation for Health Call Center.
AIS Healthcare opened its second 503A specialty compounding pharmacy in Dallas, creating a fully redundant targeted drug delivery operation that goes beyond state and industry standards to produce medications of the highest quality.
The recently released 20% subcutaneous immunoglobulin therapy expands treatment options offered by Advanced Infusion Care.